ConductScience.org, home

Paper39974366

Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients.

Vodă IM and 10 others. Front Neurol, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients. Papers, record 39974366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39974366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients.
PubMed
Journal
Front Neurol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-02-22
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vodă IMIleana Maria
2Tiu VEVlad Eugen
3Răuță LLuiza
4Ciucur PPaul
5Mușuroi AIAndreea Ioana
6Tomescu AFAlina Flavia
7Humă NLNicoleta Laura
8Dobrițoiu FFlorin
9Terecoasă EElena
10Negreanu LLucian
11Tiu CCristina

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136736346Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis.Z Gastroenterol2023https://conductscience.org/library/papers/36736346PubMed
230171504Ocrelizumab: A Review in Multiple Sclerosis.CNS Drugs2018https://conductscience.org/library/papers/30171504PubMed
333948072Ocrelizumab-induced inflammatory bowel disease-like illness characterized by esophagitis and colitis.Ann Gastroenterol2021https://conductscience.org/library/papers/33948072PubMed
430905719De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center.Clin Gastroenterol Hepatol2020https://conductscience.org/library/papers/30905719PubMed
530410033Multiple sclerosis.Nat Rev Dis Primers2018https://conductscience.org/library/papers/30410033PubMed
634513436A Review of Four Practice Guidelines of Inflammatory Bowel Disease.Cureus2021https://conductscience.org/library/papers/34513436PubMed
721098319Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma.J Clin Oncol2011https://conductscience.org/library/papers/21098319PubMed
822796801Biologic therapies: lessons from multiple sclerosis.Dig Dis2012https://conductscience.org/library/papers/22796801PubMed
931945371AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.Gastroenterology2020https://conductscience.org/library/papers/31945371PubMed
1032198886First Case of Refractory Colitis Caused by Ocrelizumab.Inflamm Bowel Dis2020https://conductscience.org/library/papers/32198886PubMed
1131753762The gut microbiome in neurological disorders.Lancet Neurol2020https://conductscience.org/library/papers/31753762PubMed
1233642561Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review.Intern Med2021https://conductscience.org/library/papers/33642561PubMed
1327934854Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.Nat Rev Neurol2017https://conductscience.org/library/papers/27934854PubMed
1438114289Histologic manifestations of ocrelizumab-associated intestinal and hepatic injury in patients with multiple sclerosis.Histopathology2024https://conductscience.org/library/papers/38114289PubMed
1538344628Two Cases of Acute Diverticulitis Following Ocrelizumab Infusion in Patients With Multiple Sclerosis.Cureus2024https://conductscience.org/library/papers/38344628PubMed
1637706452Colitis in ocrelizumab-treated patients: The dilemma of causation versus association in immune-mediated iatrogenicity.Mult Scler2023https://conductscience.org/library/papers/37706452PubMed
1731392849Environmental and genetic risk factors for MS: an integrated review.Ann Clin Transl Neurol2019https://conductscience.org/library/papers/31392849PubMed
1829358322B-Cell Therapies in Multiple Sclerosis.Cold Spring Harb Perspect Med2019https://conductscience.org/library/papers/29358322PubMed
1927741097World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015.J Clin Gastroenterol2016https://conductscience.org/library/papers/27741097PubMed
2021477588Cytokines and effector T cell subsets causing autoimmune CNS disease.FEBS Lett2011https://conductscience.org/library/papers/21477588PubMed

See all 62 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42943211Ocrelizumab-Induced Leukocyte Subpopulations Dynamics in Multiple Sclerosis.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943211PubMed
42911175Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.JAMA Neurol2026https://conductscience.org/library/papers/42911175PubMed
41693080Ocrelizumab-induced colitis: VigiBase disproportionality analysis, case reports and literature review.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41693080PubMed
41317369Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk.J Crohns Colitis2026https://conductscience.org/library/papers/41317369PubMed
41291183Longstanding histological colitis following ocrelizumab therapy: a case report.Acta Neurol Belg2026https://conductscience.org/library/papers/41291183PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39974366

GET https://conductscience.org/api/papers/v1/39974366/references?page=2